Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 8.92M $25.42M Dec. 31, 2013
BVF 7.94M $22.64M Dec. 31, 2013
Wellington Management Company 5.36M $19.18M Sept. 30, 2013
Palo Alto Investors 5.22M $14.87M Dec. 31, 2013
OppenheimerFunds 5.00M $14.25M Dec. 31, 2013
Broadfin Capital 4.96M $14.12M Dec. 31, 2013
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
Vanguard 3.77M $10.75M Dec. 31, 2013
BlackRock Fund Advisors 3.42M $9.74M Dec. 31, 2013
Millennium Management 3.28M $9.36M Dec. 31, 2013
NEA Management Company 3.24M $9.24M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 3.04M $8.66M Dec. 31, 2013
STATE STREET CORPORATION 2.27M $14.74M Dec. 31, 2013
Visium Asset Management 2.01M $5.73M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.90M $5.42M Dec. 31, 2013
HealthCor Management 1.80M $14.49M March 31, 2012
MORGAN STANLEY 1.58M $4.51M Dec. 31, 2013
HealthCor Management 1.50M $13.76M June 30, 2011
D. E. Shaw & Co 1.49M $4.25M Dec. 31, 2013
Balyasny Asset Management 1.34M $3.81M Dec. 31, 2013
NORTHERN TRUST 1.22M $3.48M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 1.19M $3.38M Dec. 31, 2013
Royce & Associates 1.15M $11.79M Sept. 30, 2012
Ameriprise Financial 1.15M $10.65M June 30, 2012
Deerfield Management Company 1.07M $3.82M Sept. 30, 2013